NO_LONGER_AVAILABLENCT01641796

Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: U.S. Army Medical Research and Development Command
Principal Investigator: Naomi Aronson, MD
Uniformed Services University of the Health Sciences
Intervention: Paromomycin(drug)
Eligibility: All sexes

Study locations (2)

Walter Reed National Military Medical Center, Bethesda, Maryland, United States
Military Treatment Facilities, Multiple Locations, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01641796 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials